Boule Diagnostics AB Stock Börse Stuttgart

Equities

8BD

SE0011231158

Advanced Medical Equipment & Technology

Market Closed - Börse Stuttgart 09:27:32 2024-05-31 EDT 5-day change 1st Jan Change
0.864 EUR +5.37% Intraday chart for Boule Diagnostics AB +3.85% -7.99%

Financials

Sales 2024 * 579M 55.01M 50.7M 74.98M Sales 2025 * 609M 57.86M 53.33M 78.87M Capitalization 396M 37.64M 34.69M 51.3M
Net income 2024 * 35M 3.33M 3.06M 4.53M Net income 2025 * 43M 4.09M 3.77M 5.57M EV / Sales 2024 * 0.77 x
Net Debt 2024 * 47.3M 4.49M 4.14M 6.13M Net Debt 2025 * 40.53M 3.85M 3.55M 5.25M EV / Sales 2025 * 0.72 x
P/E ratio 2024 *
11.2 x
P/E ratio 2025 *
9.02 x
Employees 200
Yield 2024 *
2.3%
Yield 2025 *
3.38%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.37%
1 week+3.85%
1 month+5.37%
3 months+6.01%
6 months+0.23%
Current year-7.99%
More quotes
1 week
0.81
Extreme 0.806
0.86
1 month
0.77
Extreme 0.772
0.86
Current year
0.75
Extreme 0.752
1.06
1 year
0.72
Extreme 0.716
1.06
3 years
0.72
Extreme 0.716
5.76
5 years
0.72
Extreme 0.716
7.31
10 years
0.72
Extreme 0.716
7.31
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 12-31
Human Resources Officer - 22-09-30
Corporate Officer/Principal - 11-12-31
Members of the board TitleAgeSince
Director/Board Member 71 20-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Date Price Change
24-05-31 0.864 +5.37%
24-05-30 0.82 +0.49%
24-05-29 0.816 -2.63%
24-05-28 0.838 -.--%
24-05-27 0.838 +0.72%

Delayed Quote Börse Stuttgart, May 31, 2024 at 09:27 am

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.2 SEK
Average target price
10.9 SEK
Spread / Average Target
+6.86%
Consensus